Comprehensive assessment of the combined impact of dyslipidemia and inflammation on chronic kidney disease development: A prospective cohort study

J Clin Lipidol. 2024 Mar-Apr;18(2):e251-e260. doi: 10.1016/j.jacl.2024.01.002. Epub 2024 Jan 10.

Abstract

Background: There remains a limited comprehensive understanding of how dyslipidemia and chronic inflammation collectively contribute to the development of chronic kidney disease (CKD).

Objective: We aimed to identify clusters of individuals with five variables, including lipid profiles and C-reactive protein (CRP) levels, and to assess whether the clusters were associated with incident CKD risk.

Methods: We used the Korean Genome and Epidemiology Study-Ansan and Ansung data. K-means clustering analysis was performed to identify distinct clusters based on total cholesterol, triglyceride, non-high-density lipoprotein (HDL)-C, HDL-C, and CRP levels. Cox proportional hazards models were used to examine the association between incident CKD risk and the different clusters.

Results: During the mean 10-year follow-up period, CKD developed in 1,645 participants (690 men and 955 women) among a total of 8,053 participants with a mean age of 51.8 years. Four distinct clusters were identified: C1, low cholesterol group (LC); C2, high-density lipoprotein cholesterol group (HC); C3, insulin resistance and inflammation group (IIC); and C4, dyslipidemia and inflammation group (DIC). Cluster 4 had a significantly higher risk of incident CKD compared to clusters 2 (hazard ratio (HR) 1.455 [95% confidence interval (CI) 1.234-1.715]; p < 0.001) and cluster 1 (HR 1.264 [95% CI 1.067-1.498]; p = 0.007) after adjusting for confounders. Cluster 3 had a significantly higher risk of incident CKD compared to clusters 2 and 1.

Conclusion: Clusters 4 and 3 had higher risk of incident CKD compared to clusters 2 and 1. The combination of dyslipidemia with inflammation or insulin resistance with inflammation appears to be pivotal in the development of incident CKD.

Keywords: Chronic kidney disease; Dyslipidemia; Inflammation; Insulin resistance; K-means clustering analysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • C-Reactive Protein / analysis
  • C-Reactive Protein / metabolism
  • Dyslipidemias* / blood
  • Dyslipidemias* / complications
  • Dyslipidemias* / epidemiology
  • Female
  • Humans
  • Inflammation* / blood
  • Inflammation* / complications
  • Male
  • Middle Aged
  • Prospective Studies
  • Renal Insufficiency, Chronic* / blood
  • Renal Insufficiency, Chronic* / epidemiology
  • Republic of Korea / epidemiology
  • Risk Factors

Substances

  • C-Reactive Protein